Literature DB >> 12461224

An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine.

David A Smelson1, Miklos F Losonczy, Chris Kilker, Aron Starosta, Jacob Kind, John Williams, Douglas Ziedonis.   

Abstract

OBJECTIVE: Persons with schizophrenia who are addicted to cocaine experience more psychiatric and substance abuse relapses and worse long-term outcomes than persons with only one of these conditions. This study examined whether individuals with cocaine dependence and schizophrenia experience more cue-elicited craving than those without schizophrenia.
METHODS: Ninety-one cocaine-dependent participants who had been abstinent from cocaine for at least 72 hours were recruited from substance abuse treatment programs in the Veterans Affairs New Jersey Health Care System. The study used a cue-exposure paradigm to stimulate cocaine craving. A self-report instrument was used to measure changes from baseline in four areas: craving intensity, happy or depressed mood, increased or decreased energy, and physical health or sickness.
RESULTS: The participants with schizophrenia (N=35) reported significantly more cocaine craving than those without schizophrenia (N=56). When data for participants who were cue reactive were analyzed without regard to diagnosis, 97 percent of the cocaine-dependent participants with schizophrenia were cue reactive, compared with 43 percent of those without schizophrenia.
CONCLUSIONS: Future research on cocaine dependence should focus on craving, particularly among patients with coexisting psychiatric disorders.

Entities:  

Mesh:

Year:  2002        PMID: 12461224     DOI: 10.1176/appi.ps.53.12.1612

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  8 in total

1.  A pilot study of Qigong for reducing cocaine craving early in recovery.

Authors:  David Smelson; Kevin W Chen; Douglas Ziedonis; Ken Andes; Amanda Lennox; Lanora Callahan; Stephanie Rodrigues; David Eisenberg
Journal:  J Altern Complement Med       Date:  2012-07-03       Impact factor: 2.579

Review 2.  Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Authors:  Robert M Roth; Mary F Brunette; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

3.  Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project.

Authors:  Edward W Boyer; Rich Fletcher; Richard J Fay; David Smelson; Douglas Ziedonis; Rosalind W Picard
Journal:  J Med Toxicol       Date:  2012-03

Review 4.  Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Authors:  Douglas M Ziedonis; David Smelson; Richard N Rosenthal; Steven L Batki; Alan I Green; Renata J Henry; Ivan Montoya; Joseph Parks; Roger D Weiss
Journal:  J Psychiatr Pract       Date:  2005-09       Impact factor: 1.325

5.  Increased Depression and Anxiety Symptoms are Associated with More Breakdowns in Cognitive Control to Cocaine Cues in Veterans with Cocaine Use Disorder.

Authors:  Gregory J DiGirolamo; Gerardo Gonzalez; David Smelson; Nathan Guevremont; Michael I Andre; Pooja O Patnaik; Zachary R Zaniewski
Journal:  J Dual Diagn       Date:  2017-11-09

Review 6.  The role of antipsychotics in smoking and smoking cessation.

Authors:  Annette M Matthews; Vanessa B Wilson; Suzanne H Mitchell
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

7.  Open-Label Study of Craving in Smokers With Schizophrenia Using Nicotine Nasal Spray Compared to Nicotine Patch.

Authors:  Jill M Williams; Kunal K Gandhi; Maria Katsamanis Karavidas; Marc L Steinberg; Shou-En Lu; Jonathan Foulds
Journal:  J Dual Diagn       Date:  2008-10-01

8.  Effects of smoking cues on caffeine urges in heavy smokers and caffeine consumers with and without schizophrenia.

Authors:  Amy B Adolfo; Christopher G AhnAllen; Jennifer W Tidey
Journal:  Schizophr Res       Date:  2008-11-08       Impact factor: 4.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.